VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SUPN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SUPNSupernus Pharmaceuticals, Inc.
$28.96$3.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSUPNQuarterly Financials

Supernus Pharmaceuticals, Inc. (SUPN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Supernus Pharmaceuticals, Inc. (SUPN) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

SUPN Income Statement

Quarterly statement

SUPN Income Statement

Supernus Pharmaceuticals, Inc. (SUPN) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue356M343M317M358M314M302M266M299M307M299M143.64M164.31M153.88M135.56M153.76M167.33M177.35M170.05M152.51M159.05M
Revenue Growth %13.38%13.58%19.17%19.73%2.28%1%85.18%81.97%99.51%120.56%-6.58%-1.8%-13.24%-20.28%0.82%5.2%19.46%20.32%16.48%10.79%
Cost of Goods Sold51M49M40M64M62M52M44M23M69M79M16.31M19.63M19.6M21.09M23.46M22.95M25.88M20.46M17.93M16.99M
COGS % of Revenue14.33%14.29%12.62%17.88%19.75%17.22%16.54%7.69%22.48%26.42%11.35%11.94%12.74%15.56%15.26%13.72%14.59%12.03%11.76%10.68%
Gross Profit305M294M277M294M252M250M222M276M238M220M127.33M144.69M134.28M114.47M130.3M144.37M151.47M149.59M134.57M142.06M
Gross Margin %85.67%85.71%87.38%82.12%80.25%82.78%83.46%92.31%77.52%73.58%88.65%88.06%87.26%84.44%84.74%86.28%85.41%87.97%88.24%89.32%
Gross Profit Growth %21.03%17.6%24.77%6.52%5.88%13.64%74.34%90.76%77.24%92.19%-2.28%0.22%-11.35%-23.48%-3.17%1.63%16.18%28.63%16.03%13.62%
Operating Expenses124M134M140M172M153M178M156M180M234M338M130.49M145.68M126.14M132.06M125.13M110.04M153M138.25M132.61M135.96M
OpEx % of Revenue34.83%39.07%44.16%48.04%48.73%58.94%58.65%60.2%76.22%113.04%90.84%88.66%81.97%97.42%81.38%65.76%86.27%81.3%86.95%85.48%
Selling, General & Admin119M122M124M155M133M158M132M-47M208M152M86.52M81.28M82.7M86.78M85.6M73.97M112.31M100.48M90.46M101.73M
SG&A % of Revenue33.43%35.57%39.12%43.3%42.36%52.32%49.62%-15.72%67.75%50.84%60.23%49.47%53.74%64.02%55.67%44.21%63.33%59.09%59.31%63.96%
Research & Development5M12M16M17M20M21M22M31M22M26M24.93M23.35M22.66M24.38M21.21M17.77M19.55M16.39M20.84M21.08M
R&D % of Revenue1.4%3.5%5.05%4.75%6.37%6.95%8.27%10.37%7.17%8.7%17.36%14.21%14.72%17.98%13.8%10.62%11.03%9.64%13.66%13.25%
Other Operating Expenses00000-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income181M160M137M122M99M72M66M96M4M-118M-3.15M-996K8.14M-17.59M5.18M34.33M-1.52M11.35M1.97M6.1M
Operating Margin %50.84%46.65%43.22%34.08%31.53%23.84%24.81%32.11%1.3%-39.46%-2.2%-0.61%5.29%-12.97%3.37%20.52%-0.86%6.67%1.29%3.83%
Operating Income Growth %82.83%122.22%107.58%27.08%2375%161.02%2193.24%9738.55%-50.85%-570.95%-160.92%-102.9%634.34%-255.01%163.14%463.04%-104.67%-66.74%-85.11%-85.82%
EBITDA182M163M141M127M104M77M71M101M12M-112M17.6M20.68M30M3.14M25.78M55.18M20.25M32.9M23.33M18.8M
EBITDA Margin %51.12%47.52%44.48%35.47%33.12%25.5%26.69%33.78%3.91%-37.46%12.25%12.59%19.49%2.31%16.76%32.98%11.42%19.35%15.3%11.82%
EBITDA Growth %75%111.69%98.59%25.74%766.67%168.75%303.5%388.39%-59.99%-3669.15%-31.74%-62.52%48.11%-90.46%10.49%193.45%-48.44%-19.22%17.79%-61.24%
D&A (Non-Cash Add-back)1M3M4M5M5M5M5M5M8M6M20.75M21.68M21.86M20.73M20.6M20.85M21.77M21.56M21.36M12.71M
EBIT184M162M122M87M49M77M71M101M9M-112M-4.25M990K9.89M-16.22M10.52M36.73M1.28M13.13M16.66M7.99M
Net Interest Income2M1M-4M0-6M-9M-8M-8M-5M-3M3.4M1.99M1.75M460K3.84M806K1.08M-22K12.76M-4.05M
Interest Income4M3M3M6M6M6M4M5M5M6M3.4M1.99M1.75M1.37M5.35M2.4M2.8M1.79M14.7M1.89M
Interest Expense2M2M7M6M12M15M12M13M10M9M000910K1.5M1.59M1.72M1.81M1.94M5.93M
Other Income/Expense1M0-22M-41M-62M-10M-7M-8M-5M-3M3.4M1.99M1.75M460K3.84M806K1.08M-22K12.76M-4.05M
Pretax Income182M160M115M81M37M62M59M88M-1M-121M243K990K9.89M-17.13M9.02M35.14M-444K11.32M14.72M2.05M
Pretax Margin %51.12%46.65%36.28%22.63%11.78%20.53%22.18%29.43%-0.33%-40.47%0.17%0.6%6.43%-12.63%5.86%21%-0.25%6.66%9.65%1.29%
Income Tax45M38M26M-21M-5M44M11M28M-5M-23M119K-185K25.86M-16.3M-7.93M9.66M-2.19M3.46M-10.89M-391K
Effective Tax Rate %24.73%23.75%22.61%-25.93%-13.51%70.97%18.64%31.82%500%19.01%48.97%-18.69%261.55%95.15%-87.96%27.49%493.92%30.55%-73.99%-19.06%
Net Income137M122M89M102M42M18M47M59M4M-97M124K1.18M-15.98M-831K16.95M25.48M1.75M7.87M25.62M2.44M
Net Margin %38.48%35.57%28.08%28.49%13.38%5.96%17.67%19.73%1.3%-32.44%0.09%0.72%-10.38%-0.61%11.02%15.23%0.99%4.63%16.8%1.54%
Net Income Growth %226.19%577.78%89.36%72.88%950%118.56%37803.23%4921.28%125.04%-11572.68%-99.27%-95.39%-1013.44%-110.57%-33.84%943.45%-91.89%-66.85%349.88%-92.06%
Net Income (Continuing)137M122M89M102M42M18M48M60M4M-98M124K1.18M-15.98M-831K16.95M25.48M1.75M7.87M25.62M2.44M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.120.950.690.820.330.140.380.450.03-0.720.000.02-0.29-0.020.290.430.030.140.430.04
EPS Growth %239.39%578.57%81.58%82.22%1000%119.44%-2012.68%110.34%-3500%-99.31%-95.05%-1066.67%-114.29%-32.56%975%-92.5%-67.44%290.91%-92.98%
EPS (Basic)1.160.970.710.820.340.140.380.450.03-0.720.000.02-0.29-0.020.310.470.030.150.480.05
Diluted Shares Outstanding122M129M129M125M129M123.68M123.68M128.08M133.55M134.85M55.63M55.06M54.61M54.5M62.45M62.09M55.03M61.4M61.41M54.53M
Basic Shares Outstanding118M125.35M125.35M125M125M123.68M123.68M126.61M132.1M134.85M54.8M54.57M54.61M54.5M54.38M54.1M53.79M53.43M53.33M53.24M
Dividend Payout Ratio--------------------